A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension
Clinical trial NCT03267108 · TERMINATED
Trial details
- NCT number
- NCT03267108
- Sponsor
- Bellerophon Pulse Technologies
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-14
- Primary completion
- 2023-06-09
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.